Efficacy and Safety of Alirocumab in Patients With...

The American Journal of Cardiology 2019 / 12

Efficacy and Safety of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function or Apolipoprotein B Loss-of-Function Mutations

Krempf, Michel, Hopkins, Paul N, Bruckert, Eric, Lee, Shane, Donahue, Stephen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The American Journal of Cardiology
DOI:
10.1016/j.amjcard.2019.12.028
Date:
December, 2019
File:
PDF, 1014 KB
english, 2019
Conversion to is in progress
Conversion to is failed